ASLAN Pharmaceuticals Lim...

NASDAQ: ASLN · Real-Time Price · USD
0.60
-0.10 (-14.27%)
At close: Jul 18, 2024, 10:00 PM

ASLAN Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.06 -0.16 -0.67
PEG Ratio
0.00 -0.00 -0.05
PS Ratio
0.23 n/a n/a
PB Ratio
-0.21 0.96 0.41
P/FCF Ratio
-0.06 -0.21 -0.69
P/OCF Ratio
-0.06 -0.21 -0.69
OCF/S Ratio
-3.86 n/a n/a
Debt / Equity Ratio
-2.02 4.50 0.54
Quick Ratio
1.84 2.63 14.75
Current Ratio
1.84 2.63 14.75
Asset Turnover
0.49 n/a n/a
Interest Coverage
-10.11 -13.03 -18.19
Return on Equity
3.33 -6.14 -0.61
Return on Assets
-1.8 -0.84 -0.37
Return on Invested Capital
-3.24 -1.04 -0.42
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.97 n/a n/a
Net Profit Margin
-3.68 n/a n/a
Pretax Profit Margin
-3.67 n/a n/a
Operating Profit Margin
-3.64 n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
-3.62 n/a n/a